← Back to Search

Device

transcranial direct current stimulation (tDCS) for Epilepsy

Phase < 1
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 week of end of the short treatment and within 1 week of end of the long treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a brain stimulation technique called tDCS can help reduce seizures and EEG spikes. tDCS will be done at home, and participants will be randomly assigned to either receive real tDCS or a fake (placebo) version.

Eligible Conditions
  • Partial Epilepsy
  • Epilepsy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~recorded at time of study entry (baseline) and within 1 week of end of the long treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and recorded at time of study entry (baseline) and within 1 week of end of the long treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in seizures per month
Secondary study objectives
Change in duration of seizures
Change in severity of seizures
Number of epileptiform EEG spikes

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Long StimulationExperimental Treatment1 Intervention
30 minutes duration of stimulation per day for 30 days
Group II: Short StimulationActive Control1 Intervention
1 minute duration of stimulation per day for 30 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
transcranial direct current stimulation (tDCS)
2014
N/A
~820

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,468 Previous Clinical Trials
17,496,252 Total Patients Enrolled
16 Trials studying Epilepsy
1,193 Patients Enrolled for Epilepsy
~7 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top